Cheap supplies of a groundbreaking twice-yearly HIV prevention jab will be available in many poorer countries within two years, funders have promised. Lenacapavir will cost $40 (£30) a patient a year in 120 low- and middle-income countries from 2027, under two agreements with generic drug manufacturers announced this week. Last year there were 1.3m new HIV infections globally and experts …
Read More »Cheap supplies of HIV-prevention jab for poorer countries hailed as ‘genuine chance to end’ global epidemic | Aids and HIV
